menu

Investments

Aker BioMarine

Aker BioMarine is an integrated biotechnology company that develops, markets and sells high-quality krill-based ingredients.

Aker’s engagement
Aker owns 99.51 per cent of the shares in Aker BioMarine. The shareholding is valued at NOK 1.4 billion (book value). This equates to 5 per cent of Aker’s total assets at 31 December 2015. Ola Snøve, Kjell Inge Røkke, Øyvind Eriksen and Frank O. Reite represent Aker on the company’s board of directors.

Aker’s ownership agenda
Aker BioMarine controls the entire supply chain, from sustainable krill harvesting by two environmentally (MSC) certified vessels to innovative product development, production, logistics
and long-term collaboration agreements with global consumer product and brand leaders. Demand for Qrill™ Aqua, a feed supplement for the aquaculture industry, continues to grow. Superba™ Krill Oil, the company’s brand ingredient in the Omega-3 market, has become the global market leader, taking increased market share in the last couple of years.

In its capacity as owner, Aker’s priority is to ensure that Aker BioMarine continues to build and expand the market for high-quality krill-based ingredients for use in different applications. Constant focus on reducing production costs throughout the value chain, as well as improved raw material utilisation and higher sales, will improve Aker BioMarine’s margins. Aker is continuing its efforts to crystallise underlying value in Aker BioMarine, and will in the longer term consider alternatives to render the investment more liquid.

Aker BioMarine

Geographic marked:
International

Sector:
Biomarine

Category:
Biotechnology

Share of Aker's gross asset value (4Q15)
5%

CEO & President:
Matts Johansen

Board Chairman:
Ola Snøve

Website:
www.akerbiomarine.com